Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Christina C Jones \"Christy\"
AddedMar 31, 2024
UpdatedMay 1, 2026
Christina C Jones \"Christy\"

Christina C Jones \"Christy\"

Board Member, Extend Fertility

Christina C Jones \"Christy\"'s Career

Extend Fertility
Extend Fertility

New York City, NY, US

Board Member· Board
Beta Bionics
Beta Bionics

Irvine, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Christina C Jones \"Christy\"'s Career

Extend Fertility
Extend Fertility
Series A$15M362015New York City, NY, US
Board Member· Board

Leadership at Extend Fertility

Joshua U. KleinJoshua U. KleinFounder
Anne HogartyAnne HogartyCEO

Similar to Extend Fertility

Future FamilyFuture FamilySan Francisco, CA, USFertility Careest. 2016Future FamilySan Francisco, CA, US · est. 2016

Future Family: Affordable, personalized fertility care through subscription IVF and egg freezing.

Series B · $148.2M80
She's WellShe's WellSan Francisco, CA, USEgg Freezing, Fertility Servicesest. 2018She's WellSan Francisco, CA, US · est. 2018

She's Well: A subscription service aiding fertility preservation for future family planning.

Seed · $2.1M125
Beta Bionics
Beta Bionics
Series D$293.5M1602015Irvine, CA, US
Board Member· Board

Leadership at Beta Bionics

Sean SaintSean SaintCEO
Ed DamianoEd DamianoCo-Founder
Firas El-KhatibFiras El-KhatibCo-Founder
Gilad GlickGilad GlickBoard Member
Edward RaskinEdward RaskinCo-Founder
Beth BrookeBeth BrookeBoard Member

Similar to Beta Bionics

Open BionicsOpen BionicsCollege Green, Bristol, Bristol, GBMedical Devices, Prostheticsest. 2014Open BionicsCollege Green, Bristol, Bristol, GB · est. 2014

Open Bionics: Creating affordable, 3D-printed prosthetic limbs for amputees and researchers.

Seed · $12.2M43
Wave TherapeuticsWave TherapeuticsNashville, IN, USMedical Devicesest. 2019Wave TherapeuticsNashville, IN, US · est. 2019

Wave Therapeutics: Innovating life-saving, cost-reducing pressure injury prevention technology.

Seed · $1.1M3
KneevoiceKneevoiceSanta Monica, CA, USDiagnostics, HealthTechest. 2015KneevoiceSanta Monica, CA, US · est. 2015

Kneevoice: Innovating digital diagnostics for optimal knee health and wellness.

Pre-Seed · $1.4M6
NovaXS BiotechNovaXS BiotechBerkeley, CA, USHealthcare Servicesest. 2021NovaXS BiotechBerkeley, CA, US · est. 2021

NovaXS: A healthcare startup offering personalized in-home diagnosis, prevention, and treatment.

Seed · $1.9M13

Christina C Jones \"Christy\"'s Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Christina C Jones \"Christy\"

Christina H.Christina H.Co-Founder · EvenUpChristine M CournoyerChristine M CournoyerBoard Member · Spok HoldingsChristine SheehyChristine SheehyBoard Member · Vinings HoldingsChristopher Mews \"Chris\"Christopher Mews \"Chris\"Board Member · 1PageChristobel E SeleckyChristobel E SeleckyBoard Member · NantkwestChristina L AhmadjianChristina L AhmadjianBoard Member · Asahi Group Holdings